Not for everyone. See article below for details.
"On July 30, 2021, again having concluded that revising this EUA is appropriate to protect the
public health or safety under section 564(g)(2) of the Act, FDA is reissuing the June 3, 2021
letter in its entirety, to also authorize REGEN-COV for emergency use as post-exposure
prophylaxis in certain adults and pediatric individuals. Clarifying revisions to the conditions on
good manufacturing practices as well as advertising and promotion have also been incorporated"
https://www.fda.gov/media/145610/download
"On July 30, 2021, again having concluded that revising this EUA is appropriate to protect the
public health or safety under section 564(g)(2) of the Act, FDA is reissuing the June 3, 2021
letter in its entirety, to also authorize REGEN-COV for emergency use as post-exposure
prophylaxis in certain adults and pediatric individuals. Clarifying revisions to the conditions on
good manufacturing practices as well as advertising and promotion have also been incorporated"
https://www.fda.gov/media/145610/download